|
1
|
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S,
Nice EC, Tang J and Huang C: Oral squamous cell carcinomas: State
of the field and emerging directions. Int J Oral Sci. 15:442023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hedberg ML, Goh G, Chiosea SI, Bauman JE,
Freilino ML, Zeng Y, Wang L, Diergaarde BB, Gooding WE, Lui VW, et
al: Genetic landscape of metastatic and recurrent head and neck
squamous cell carcinoma. J Clin Invest. 126:169–180. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lo Nigro C, Denaro N, Merlotti A and
Merlano M: Head and neck cancer: Improving outcomes with a
multidisciplinary approach. Cancer Manag Res. 9:363–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han H, Yang C, Zhang S, Cheng M, Guo S,
Zhu Y, Ma J, Liang Y, Wang L, Zheng S, et al: METTL3-mediated
m6A mRNA modification promotes esophageal cancer
initiation and progression via Notch signaling pathway. Mol Ther
Nucleic Acids. 26:333–346. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Z, Chen J, Xu X, Li Q, Zhang C, Li S,
Liu L, Cao C, Chen D and He Q: METTL3-mediated ALDH m6A
methylation regulates the malignant behavior of BMI1+
HNSCC stem cells. Oral Dis. 30:1061–1071. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan L, She H, Wang K, Xia W, Tang H, Fan Y
and Ye J: Characterization of the m6A regulator-mediated
methylation modification patterns in oral squamous cell carcinoma.
Sci Rep. 13:66172023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qin Z, Bai J, He H and Li B: Expression
and significance of m6A-RNA-methylation in oral cancer
and precancerous lesion. Front Oncol. 13:10130542023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Wu H, Wang Q, Ning S, Xu S and Pang
D: Dual effects of N6-methyladenosine on cancer
progression and immunotherapy. Mol Ther Nucleic Acids. 24:25–39.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qi YN, Liu Z, Hong LL, Li P and Ling ZQ:
Methyltransferase-like proteins in cancer biology and potential
therapeutic targeting. J Hematol Oncol. 16:892023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing M, Liu Q, Mao C, Zeng H, Zhang X,
Zhao S, Chen L, Liu M, Shen B, Guo X, et al: The 18S rRNA
m6 A methyltransferase METTL5 promotes mouse embryonic
stem cell differentiation. EMBO Rep. 21:e498632020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ignatova VV, Stolz P, Kaiser S, Gustafsson
TH, Lastres PR, Sanz-Moreno A, Cho YL, Amarie OV, Aguilar-Pimentel
A, Klein-Rodewald T, et al: The rRNA m6A
methyltransferase METTL5 is involved in pluripotency and
developmental programs. Genes Dev. 34:715–729. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Liang Y, Lin R, Xiong Q, Yu P, Ma
J, Cheng M, Han H, Wang X, Wang G, et al: Mettl5 mediated 18S rRNA
N6-methyladenosine (m6A) modification controls stem cell
fate determination and neural function. Genes Dis. 9:268–274. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Ma H, Ma L, Li K and Kang Y: The
potential role of methyltransferase-like 5 in deficient mismatch
repair of uterine corpus endometrial carcinoma. Bioengineered.
13:5525–5536. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Liu J, Yang Y, Xing C, Jing J and
Yuan Y: Expression and prognostic potential of ribosome 18S RNA
m6A methyltransferase METTL5 in gastric cancer. Cancer
Cell Int. 21:5692021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shinde H and Kadam US: Growing prospects
of RNA therapeutics: A case of METTL5 and 18S rRNA m6A
modification. Mol Ther. 32:11–12. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Tran N, Ernst FGM, Hawley BR, Zorbas
C, Ulryck N, Hackert P, Bohnsack KE, Bohnsack MT, Jaffrey SR,
Graille M and Lafontaine DLJ: The human 18S rRNA m6A
methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids
Res. 47:7719–7733. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen B, Huang Y, He S, Yu P, Wu L and Peng
H: N6-methyladenosine modification in 18S rRNA promotes
tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53
axis. Cell Chem Biol. 30:144–158.e10. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei Z, Chen Y, Zeng Z, Peng Y, Li L, Hu N,
Gao X, Cai W, Yin L, Xu Y, et al: The novel m6A writer METTL5 as
prognostic biomarker probably associating with the regulation of
immune microenvironment in kidney cancer. Heliyon. 8:e120782022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun S, Fei K, Zhang G, Wang J, Yang Y, Guo
W, Yang Z, Wang J, Xue Q, Gao Y and He J: Construction and
comprehensive analyses of a METTL5-associated prognostic signature
with immune implication in lung adenocarcinomas. Front Genet.
11:6171742020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia P, Zhang H, Lu H, Xu K, Jiang X, Jiang
Y, Gongye X, Chen Z, Liu J, Chen X, et al: METTL5 stabilizes c-Myc
by facilitating USP5 translation to reprogram glucose metabolism
and promote hepatocellular carcinoma progression. Cancer Commun
(Lond). 43:338–364. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L and Peng JL: METTL5 serves as a
diagnostic and prognostic biomarker in hepatocellular carcinoma by
influencing the immune microenvironment. Sci Rep. 13:107552023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rong B, Zhang Q, Wan J, Xing S, Dai R, Li
Y, Cai J, Xie J, Song Y, Chen J, et al: Ribosome 18S m6A
Methyltransferase METTL5 promotes translation initiation and breast
cancer cell growth. Cell Rep. 33:1085442020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang H, Heo S, Shin JJ, Ji E, Tak H, Ahn
S, Lee KJ, Lee EK and Kim W: A miR-194/PTBP1/CCND3 axis regulates
tumor growth in human hepatocellular carcinoma. J Pathol.
249:395–408. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sloan KE, Warda AS, Sharma S, Entian KD,
Lafontaine DLJ and Bohnsack MT: Tuning the ribosome: The influence
of rRNA modification on eukaryotic ribosome biogenesis and
function. RNA Biol. 14:1138–1152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burman LG and Mauro VP: Analysis of rRNA
processing and translation in mammalian cells using a synthetic 18S
rRNA expression system. Nucleic Acids Res. 40:8085–8098. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Noller HF: Ribosomal RNA and translation.
Annu Rev Biochem. 60:191–227. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tian S, Lai J, Yu T, Li Q and Chen Q:
Regulation of gene expression associated with the
N6-Methyladenosine (m6A) enzyme system and its significance in
cancer. Front Oncol. 10:6236342021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sepich-Poore C, Zheng Z, Schmitt E, Wen K,
Zhang ZS, Cui XL, Dai Q, Zhu AC, Zhang L, Sanchez Castillo A, et
al: The METTL5-TRMT112 N6-methyladenosine
methyltransferase complex regulates mRNA translation via 18S rRNA
methylation. J Biol Chem. 298:1015902022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng H, Chen B, Wei W, Guo S, Han H, Yang
C, Ma J, Wang L, Peng S, Kuang M and Lin S:
N6-methyladenosine (m6A) in 18S rRNA promotes
fatty acid metabolism and oncogenic transformation. Nat Metab.
4:1041–1054. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai Z, Zhu W, Hou Y, Zhang X, Ren X, Lei
K, Liao J, Liu H, Chen Z, Peng S, et al: METTL5-mediated 18S rRNA
m6A modification promotes oncogenic mRNA translation and
intrahepatic cholangiocarcinoma progression. Mol Ther.
31:3225–3242. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lei K, Lin S and Yuan Q:
N6-methyladenosine (m6A) modification of
ribosomal RNAs (rRNAs): Critical roles in mRNA translation and
diseases. Genes Dis. 10:126–134. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hua W, Li Y, Yin H, Du KX, Zhang XY, Wu
JZ, Liang JH, Shen HR, Gao R, Li JY, et al: Analysis of CCND3
mutations in diffuse large B-cell lymphoma. Ann Hematol.
103:5729–5739. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koo KH and Kwon H: MicroRNA miR-4779
suppresses tumor growth by inducing apoptosis and cell cycle arrest
through direct targeting of PAK2 and CCND3. Cell Death Dis.
9:772018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ribeiro IP, Rodrigues JM, Mascarenhas A,
Kosyakova N, Caramelo F, Liehr T, Melo JB and Carreira IM:
Cytogenetic, genomic, and epigenetic characterization of the HSC-3
tongue cell line with lymph node metastasis. J Oral Sci. 60:70–81.
2018. View Article : Google Scholar : PubMed/NCBI
|
